Short description
Olymvax is a pharmaceutical company involved in the research and development of human vaccines.
Description
Olymvax is a biopharmaceutical firm that develops, manufactures, and sells human vaccinations. They are integrating global resources, maintaining cooperation with all parties, and striving to develop technological innovation for the development of vaccines. Their products include the tetanus vaccine and the Haemophilus influenzae B vaccine.
Last funding
Blurry Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Chengdu, Sichuan, China, Asia
Founded on
December 11, 2009
Exited on
September 15, 2015
Went public on
September 15, 2015
Stock symbol
833577
Non-profit?
No
Acquired?
No
Employees count
251-500